SERA PROGNOSTICS, INC. Prepaid Expense and Other Assets, Current
SERA PROGNOSTICS, INC. (SERA) had Prepaid Expense and Other Assets, Current of $1.68 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-12
- 2026-06-30: Prepaid Expense and Other Assets, Current $1.68M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $2.31M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $1.56M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $1.17M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.68M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $2.31M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $1.56M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $1.17M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $693.00K 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $1.06M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $1.33M 10-K · filed 2026-03-18 | $1.31M 10-K · filed 2025-03-19 |
| 2024-09-30 | $1.28M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $502.00K 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $756.00K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $795.00K 10-K · filed 2025-03-19 | |
| 2023-09-30 | $1.27M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $444.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $1.20M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $1.31M 10-K · filed 2024-03-20 | |
| 2022-09-30 | $1.95M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $1.01M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $1.88M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $1.99M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $2.33M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $503.00K 10-Q · filed 2021-08-30 | |
| 2020-12-31 | $198.00K 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |